Response
Access to needle and syringe programs by people who inject image and performance enhancing drugs

https://doi.org/10.1016/j.drugpo.2016.01.016Get rights and content

References (16)

  • I. van Beek et al.

    Performance and image enhancing drug injectors’ access to needle syringe programs: Responding to a public policy dilemma

    International Journal of Drug Policy

    (2015)
  • K.J. Cullen et al.

    Risk and vulnerability among people who inject image and performance enhancing drugs in England and Wales 2012–2013: Where should we focus harm reduction?

  • C.A. Day et al.

    Blood-borne virus prevalence and risk among steroid injectors: Results from the Australian Needle and Syringe Program Survey

    Drug and Alcohol Review

    (2008)
  • V.D. Hope et al.

    Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: A cross-sectional study

    BMJ Open

    (2013)
  • V.D. Hope et al.

    Injection site infections and injuries in men who inject image- and performance-enhancing drugs: Prevalence, risks factors, and healthcare seeking

    Epidemiology & Infection

    (2015)
  • J. Iversen et al.

    Are people who inject performance and image-enhancing drugs an increasing population of Needle and Syringe Program attendees?

    Drug and Alcohol Review

    (2013)
  • J.A. Kwon et al.

    Estimating the cost-effectiveness of needle–syringe programs in Australia

    AIDS

    (2012)
There are more references available in the full text version of this article.

Cited by (0)

View full text